306 related articles for article (PubMed ID: 21868696)
21. Aptamer therapy for heart failure?
Port JD; Bristow MR
Circ Res; 2011 Oct; 109(9):982-3. PubMed ID: 21998296
[No Abstract] [Full Text] [Related]
22. The beta-adrenergic receptors.
Wallukat G
Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
[TBL] [Abstract][Full Text] [Related]
23. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure.
Nikolaev VO; Boivin V; Störk S; Angermann CE; Ertl G; Lohse MJ; Jahns R
J Am Coll Cardiol; 2007 Jul; 50(5):423-31. PubMed ID: 17662395
[TBL] [Abstract][Full Text] [Related]
24. Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy.
Wess G; Wallukat G; Fritscher A; Becker NP; Wenzel K; Müller J; Schimke I
PLoS One; 2019; 14(7):e0214263. PubMed ID: 31276517
[TBL] [Abstract][Full Text] [Related]
25. Aptamer BC 007 - A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors.
Haberland A; Holtzhauer M; Schlichtiger A; Bartel S; Schimke I; Müller J; Dandel M; Luppa PB; Wallukat G
Eur J Pharmacol; 2016 Oct; 789():37-45. PubMed ID: 27375076
[TBL] [Abstract][Full Text] [Related]
26. Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes.
Podlowski S; Luther HP; Morwinski R; Müller J; Wallukat G
Circulation; 1998 Dec; 98(22):2470-6. PubMed ID: 9832494
[TBL] [Abstract][Full Text] [Related]
27. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study.
Deubner N; Berliner D; Schlipp A; Gelbrich G; Caforio AL; Felix SB; Fu M; Katus H; Angermann CE; Lohse MJ; Ertl G; Störk S; Jahns R;
Eur J Heart Fail; 2010 Jul; 12(7):753-62. PubMed ID: 20494925
[TBL] [Abstract][Full Text] [Related]
28. Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells.
Tutor AS; Penela P; Mayor F
Cardiovasc Res; 2007 Oct; 76(1):51-60. PubMed ID: 17628514
[TBL] [Abstract][Full Text] [Related]
29. Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops.
Wallukat G; Wollenberger A; Morwinski R; Pitschner HF
J Mol Cell Cardiol; 1995 Jan; 27(1):397-406. PubMed ID: 7539084
[TBL] [Abstract][Full Text] [Related]
30. Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes.
Christ T; Adolph E; Schindelhauer S; Wettwer E; Dobrev D; Wallukat G; Ravens U
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):445-52. PubMed ID: 15910408
[TBL] [Abstract][Full Text] [Related]
31. High throughput bioassay for beta1-adrenoceptor autoantibody detection.
Joshi-Barr S; Haberland A; Bartel S; Müller J; Choi T; Wallukat G
Int J Cardiol; 2016 Sep; 219():98-104. PubMed ID: 27332740
[TBL] [Abstract][Full Text] [Related]
32. The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes.
Werner S; Wallukat G; Becker NP; Wenzel K; Müller J; Schimke I; Wess G
ESC Heart Fail; 2020 Jun; 7(3):844-855. PubMed ID: 32212256
[TBL] [Abstract][Full Text] [Related]
33. Effects of autoantibodies removed by immunoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes.
Chen J; Larsson L; Haugen E; Fedorkova O; Angwald E; Waagstein F; Fu M
Eur J Heart Fail; 2006 Aug; 8(5):460-7. PubMed ID: 16469538
[TBL] [Abstract][Full Text] [Related]
34. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
Jahns R; Boivin V; Lohse MJ
Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696
[TBL] [Abstract][Full Text] [Related]
35. [Antibodies against the second extracellular loop of beta1-adrenergic receptor induce aortic endothelial dysfunction in Wistar rat].
Abdelkrim MA; Noireaud J; Chatagnon G; Gogny M; Desfontis JC; Mallem MY
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):167-72. PubMed ID: 22633471
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy.
Wallukat G; Nissen E; Morwinski R; Müller J
Herz; 2000 May; 25(3):261-6. PubMed ID: 10904849
[TBL] [Abstract][Full Text] [Related]
37. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
Dandel M; Wallukat G; Englert A; Hetzer R
Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
[TBL] [Abstract][Full Text] [Related]
38. Determination of Agonistically Acting Autoantibodies to the Adrenergic Beta-1 Receptor by Cellular Bioassay.
Davideit H; Haberland A; Bartel S; Schulze-Rothe S; Müller J; Wenzel K
Methods Mol Biol; 2019; 1901():95-102. PubMed ID: 30539571
[TBL] [Abstract][Full Text] [Related]
39. Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.
Wallukat G; Schimke I
Semin Immunopathol; 2014 May; 36(3):351-63. PubMed ID: 24777744
[TBL] [Abstract][Full Text] [Related]
40. Decreased autophagy in rat heart induced by anti-β1-adrenergic receptor autoantibodies contributes to the decline in mitochondrial membrane potential.
Wang L; Lu K; Hao H; Li X; Wang J; Wang K; Wang J; Yan Z; Zhang S; Du Y; Liu H
PLoS One; 2013; 8(11):e81296. PubMed ID: 24278413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
